Valorising and creating access to innovative medicines in the European Union

Valorising and creating access to innovative medicines in the European Union

This Perspective describes (a) the current situation, (b) challenges and initiatives, (c) and formulates recommendations to valorize and create access to innovative medicines in the EU. We are currently still far away from optimal assessment of value for money in the EU. On the one hand, valorizing...

Full description

Bibliographic Details
Main Authors: Lieven eAnnemans, Irina eCleemput, Frank eHulstaert, Steven eSimoens
Format: Article
Language:English
Published: Frontiers Media S.A. 2011-10-01
Series:Frontiers in Pharmacology
Subjects:
Cost-Effectiveness
Health Technology Assessment
access
budget impact
medical need
pharmaceutical innovation
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2011.00057/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fphar.2011.00057/full

Similar Items